CEL SCI Corp (CVM) KPIs and segments

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$1.19−0.12 (-9.16%)

Close on Nov 12, 2026Market cap $20.93MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Cel Sci's business

Coming soon

This tab will track the numbers specific to Cel Sci's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?